FXR activation inhibits BAs production and BAs influx, promotes BAs efflux, and thus alleviates the excessive accumulation of BAs caused by liver disease.377 Currently, the most widely used FXR agonists contain primarily BA derivatives, steroidal compounds, and nonsteroidal compounds (Table 2). The gene discussed is NR1H4; the disease is liver disorder.